Form 4 for KMDA KAMADA LTD
Accepted 2026-09-08 07:00:27 ET · period of report 2026-09-02 · accession 0001213900-26-097829 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-09-08 07:00 | 2026-09-02 | KMDA | Tsur David | Dir | M - OptEx | $6.71 | +49.0K | 630.4K | +8% | +$328.7K |
| DM | 2026-09-08 07:00 | 2026-09-02 | KMDA | Tsur David | Dir | F - Tax | $8.27 | -9,166 | 607.9K | -1% | -$75.8K |
| DMI | 2026-09-08 07:00 | 2026-09-02 | KMDA | Tsur David | Dir | M - OptEx | $0.00 | -49.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-09-02 | M | A | 26,500 | $7.36 | 634,429 | D | — | — | (F1) All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. (F4) This option was previously reported as covering 26,500 ordinary shares at an exercise price of $7.53. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026. |
| 2 | Common | Ordinary Shares | 2026-09-02 | F | D | 2,760 | $8.30 | 607,929 | D | — | — | (F2) Represents a "net exercise" of outstanding stock options. The reporting person received 2,760 ordinary shares on net exercise of option to purchase 26,500 ordinary shares. The Company withheld 23,740 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 2, 2026 of $8.30, pursuant to the terms of the Company's 2011 Share Award Plan. (F1) All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. |
| 3 | Common | Ordinary Shares | 2026-09-02 | M | A | 22,500 | $5.94 | 630,429 | D | — | — | (F1) All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. (F5) This option was previously reported as covering 22,500 ordinary shares at an exercise price of $6.11. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026. |
| 4 | Common | Ordinary Shares | 2026-09-02 | F | D | 6,406 | $8.26 | 607,929 | D | — | — | (F3) Represents a "net exercise" of outstanding stock options. The reporting person received 6,406 ordinary shares on net exercise of option to purchase 22,500 ordinary shares. The Company withheld 16,094 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 2, 2026 of $8.26, pursuant to the terms of the Company's 2011 Share Award Plan. (F1) All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. |
| 5 | Derivative | Employee Stock Option (right to buy) | 2026-09-02 | M | D | 26,500 | $0.00 | 0 | I Held by trustee | $7.36 · — to — | 26,500 Ordinary Shares | (F1) All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. (F4) This option was previously reported as covering 26,500 ordinary shares at an exercise price of $7.53. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026. (F6) The options vested over a period of four years in four equal installments, such that 25% of the options vested on each anniversary of the grant date. (F6) The options vested over a period of four years in four equal installments, such that 25% of the options vested on each anniversary of the grant date. (F7) Held by trustee under the Company's 2011 Share Award Plan. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2026-09-02 | M | D | 22,500 | $0.00 | 0 | I Held by trustee | $5.94 · — to — | 22,500 Ordinary Shares | (F1) All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. (F5) This option was previously reported as covering 22,500 ordinary shares at an exercise price of $6.11. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026. (F6) The options vested over a period of four years in four equal installments, such that 25% of the options vested on each anniversary of the grant date. (F6) The options vested over a period of four years in four equal installments, such that 25% of the options vested on each anniversary of the grant date. (F7) Held by trustee under the Company's 2011 Share Award Plan. |